Literature DB >> 23639968

Arginase II inhibited lipopolysaccharide-induced cell death by regulation of iNOS and Bcl-2 family proteins in macrophages.

Eun Ji Lee1, Yu Ran Lee, Hee Kyoung Joo, Eun Jung Cho, Sunga Choi, Kyung-Cheol Sohn, Sang Do Lee, Jin Bong Park, Byeong Hwa Jeon.   

Abstract

Arginase II catalyzes the conversion of arginine to urea and ornithine in many extrahepatic tissues. We investigated the protective role of arginase II on lipopolysaccharide-mediated apoptosis in the macrophage cells. Adenoviral gene transfer of full length of arginase II was performed in the murine macrophage cell line RAW264.7. The role of arginase II was investigated with cell viability, cytoplasmic histone-associated DNA fragmentation assay, arginase activity, nitric oxide production, and Western blot analysis. Arginase II is localized in mitochondria of macrophage cells, and the expression of arginase II was increased by lipopolysaccharide (LPS). LPS significantly increased cell death which was inhibited by AMT, a specific inducible nitric oxide synthase (iNOS) inhibitor. In contrast, LPS-induced cell death and nitric oxide production were increased by 2-boronoethyl-L-cysteine, a specific inhibitor of arginase. Adenoviral overexpression of arginase II significantly inhibited LPS-induced cell death and cytoplasmic histone-associated DNA fragmentation. LPS-induced iNOS expression and poly ADP-ribose polymerase cleavage were significantly suppressed by arginase II overexpression. Furthermore, arginase II overexpression resulted in a decrease in the Bax protein level and the reverse induction of Bcl-2 protein. Our data demonstrated that inhibition of NO production by arginase II may be due to arginine depletion as well as iNOS suppression though its reaction products. Moreover, arginase II plays a protective role of LPS-induced apoptosis in RAW264.7 cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23639968      PMCID: PMC3887864          DOI: 10.1007/s10059-013-2332-7

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  25 in total

Review 1.  Nitric oxide: pathophysiological mechanisms.

Authors:  S S Gross; M S Wolin
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

Review 2.  BCL-2 family: regulators of cell death.

Authors:  D T Chao; S J Korsmeyer
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

3.  Peripheral benzodiazepine receptor regulates vascular endothelial activations via suppression of the voltage-dependent anion channel-1.

Authors:  Hee Kyoung Joo; Yu Ran Lee; Sun Young Lim; Eun Ji Lee; Sunga Choi; Eun Jung Cho; Myoung Soo Park; Sungwoo Ryoo; Jin Bong Park; Byeong Hwa Jeon
Journal:  FEBS Lett       Date:  2012-03-31       Impact factor: 4.124

4.  Urea-induced inducible nitric oxide synthase inhibition and macrophage proliferation.

Authors:  T Moeslinger; P G Spieckermann
Journal:  Kidney Int Suppl       Date:  2001-02       Impact factor: 10.545

5.  Apurinic/apyrimidinic endonuclease 1 regulates endothelial NO production and vascular tone.

Authors:  Byeong Hwa Jeon; Gaurav Gupta; Young Chul Park; Bing Qi; Azeb Haile; Firdous A Khanday; Yan-Xia Liu; Jin-Man Kim; Michitaka Ozaki; Anthony R White; Dan E Berkowitz; Kaikobad Irani
Journal:  Circ Res       Date:  2004-10-07       Impact factor: 17.367

Review 6.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

7.  Design and synthesis of urea and thiourea derivatives and their inhibitory activities on lipopolysaccharide-induced NO production.

Authors:  Yoon Jung Kim; Jae-Ha Ryu; Ye Jin Cheon; Hyo Jin Lim; Raok Jeon
Journal:  Bioorg Med Chem Lett       Date:  2007-04-06       Impact factor: 2.823

8.  Structure of the murine arginase II gene.

Authors:  O Shi; D Kepka-Lenhart; S M Morris; W E O'Brien
Journal:  Mamm Genome       Date:  1998-10       Impact factor: 2.957

9.  Novel potent and selective inhibitors of inducible nitric oxide synthase.

Authors:  M Nakane; V Klinghofer; J E Kuk; J L Donnelly; G P Budzik; J S Pollock; F Basha; G W Carter
Journal:  Mol Pharmacol       Date:  1995-04       Impact factor: 4.436

10.  Vasorelaxing Activity of Ulmus davidiana Ethanol Extracts in Rats: Activation of Endothelial Nitric Oxide Synthase.

Authors:  Eun Jung Cho; Myoung Soo Park; Sahng Seop Kim; Gun Kang; Sunga Choi; Yoo Rhan Lee; Seok Jong Chang; Kwon Ho Lee; Sang Do Lee; Jin Bong Park; Byeong Hwa Jeon
Journal:  Korean J Physiol Pharmacol       Date:  2011-12-27       Impact factor: 2.016

View more
  5 in total

1.  Supplemental carvacrol can reduce the severity of inflammation by influencing the production of mediators of inflammation.

Authors:  Mehmet Kara; Sema Uslu; Fatih Demirci; Halide Edip Temel; Canan Baydemir
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

2.  Cytoplasmic localization and redox cysteine residue of APE1/Ref-1 are associated with its anti-inflammatory activity in cultured endothelial cells.

Authors:  Myoung Soo Park; Cuk-Seong Kim; Hee Kyoung Joo; Yu Ran Lee; Gun Kang; Soo Jin Kim; Sunga Choi; Sang Do Lee; Jin Bong Park; Byeong Hwa Jeon
Journal:  Mol Cells       Date:  2013-11-06       Impact factor: 5.034

3.  Downregulation of L-arginine metabolism in dendritic cells induces tolerance to exogenous antigen.

Authors:  Patricia U Simioni; Luis Gr Fernandes; Wirla Msc Tamashiro
Journal:  Int J Immunopathol Pharmacol       Date:  2017-01-24       Impact factor: 3.219

4.  Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages.

Authors:  Jennifer K Dowling; Remsha Afzal; Linden J Gearing; Mariana P Cervantes-Silva; Stephanie Annett; Gavin M Davis; Chiara De Santi; Nadine Assmann; Katja Dettmer; Daniel J Gough; Glenn R Bantug; Fidinny I Hamid; Frances K Nally; Conor P Duffy; Aoife L Gorman; Alex M Liddicoat; Ed C Lavelle; Christoph Hess; Peter J Oefner; David K Finlay; Gavin P Davey; Tracy Robson; Annie M Curtis; Paul J Hertzog; Bryan R G Williams; Claire E McCoy
Journal:  Nat Commun       Date:  2021-03-05       Impact factor: 14.919

5.  Enhancing arginase 2 expression using target site blockers as a strategy to modulate macrophage phenotype.

Authors:  Chiara De Santi; Frances K Nally; Remsha Afzal; Conor P Duffy; Stephen Fitzsimons; Stephanie L Annett; Tracy Robson; Jennifer K Dowling; Sally-Ann Cryan; Claire E McCoy
Journal:  Mol Ther Nucleic Acids       Date:  2022-08-04       Impact factor: 10.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.